Skip to main content

Processa Pharmaceuticals, Inc.

PCSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001533743

In the last 90 days, Processa Pharmaceuticals, Inc. insiders filed 5 open-market purchases and 0 sales; 12 institutions reported holding it in 13F filings for Q2 2026, worth $498.3K in total; no superinvestor holds it.

Superinvestors holding PCSA, Q2 2026

See all superinvestors

No superinvestor reported holding PCSA in Q2 2026.